Search by Drug Name or NDC

    NDC 51655-0725-52 hydroxyzine pamoate 25 mg/1 Details

    hydroxyzine pamoate 25 mg/1

    hydroxyzine pamoate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is HYDROXYZINE PAMOATE.

    Product Information

    NDC 51655-0725
    Product ID 51655-725_db898bc1-a73a-e62e-e053-2995a90a3d81
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name hydroxyzine pamoate
    Proprietary Name Suffix n/a
    Non-Proprietary Name hydroxyzine pamoate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name HYDROXYZINE PAMOATE
    Labeler Name Northwind Pharmaceuticals
    Pharmaceutical Class Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201507
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0725-52 (51655072552)

    NDC Package Code 51655-725-52
    Billing NDC 51655072552
    Package 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-725-52)
    Marketing Start Date 2021-06-11
    NDC Exclude Flag N
    Pricing Information N/A